End-of-day quote
Shanghai S.E.
23:00:00 27/06/2024 BST
|
5-day change
|
1st Jan Change
|
10.96
CNY
|
-1.97%
|
|
+2.81%
|
-36.36%
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
5,319
|
8,417
|
6,061
|
5,438
|
Enterprise Value (EV)
1 |
3,755
|
6,808
|
4,433
|
3,869
|
P/E ratio
|
28.3
x
|
26.4
x
|
20.1
x
|
43.8
x
|
Yield
|
1.61%
|
1.85%
|
3.72%
|
-
|
Capitalization / Revenue
|
10.8
x
|
9.57
x
|
5.35
x
|
8.05
x
|
EV / Revenue
|
7.66
x
|
7.74
x
|
3.91
x
|
5.73
x
|
EV / EBITDA
|
20.9
x
|
19.8
x
|
13.7
x
|
30.7
x
|
EV / FCF
|
36.7
x
|
93.3
x
|
-202
x
|
70.6
x
|
FCF Yield
|
2.72%
|
1.07%
|
-0.49%
|
1.42%
|
Price to Book
|
2.7
x
|
3.83
x
|
2.58
x
|
2.42
x
|
Nbr of stocks (in thousands)
|
315,787
|
315,787
|
315,787
|
315,787
|
Reference price
2 |
16.84
|
26.66
|
19.19
|
17.22
|
Announcement Date
|
25/04/21
|
30/03/22
|
24/04/23
|
26/04/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
650
|
602
|
490.3
|
880
|
1,134
|
675.2
|
EBITDA
1 |
252.1
|
262.1
|
180
|
344
|
323.3
|
125.9
|
EBIT
1 |
236.3
|
239.9
|
156.2
|
319.1
|
285.2
|
79
|
Operating Margin
|
36.35%
|
39.85%
|
31.85%
|
36.27%
|
25.16%
|
11.7%
|
Earnings before Tax (EBT)
1 |
249.7
|
252.5
|
182.9
|
369.4
|
346.4
|
141.3
|
Net income
1 |
211.1
|
219.4
|
157.3
|
319.4
|
301.7
|
123.4
|
Net margin
|
32.48%
|
36.45%
|
32.09%
|
36.3%
|
26.62%
|
18.28%
|
EPS
2 |
0.9557
|
0.9261
|
0.5961
|
1.010
|
0.9571
|
0.3929
|
Free Cash Flow
1 |
144.8
|
75.61
|
102.3
|
73
|
-21.92
|
54.82
|
FCF margin
|
22.28%
|
12.56%
|
20.87%
|
8.3%
|
-1.93%
|
8.12%
|
FCF Conversion (EBITDA)
|
57.43%
|
28.85%
|
56.84%
|
21.22%
|
-
|
43.55%
|
FCF Conversion (Net income)
|
68.58%
|
34.46%
|
65.03%
|
22.85%
|
-
|
44.41%
|
Dividend per Share
|
-
|
-
|
0.2709
|
0.4926
|
0.7143
|
-
|
Announcement Date
|
10/08/20
|
10/08/20
|
25/04/21
|
30/03/22
|
24/04/23
|
26/04/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
231
|
292
|
1,563
|
1,609
|
1,628
|
1,570
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
145
|
75.6
|
102
|
73
|
-21.9
|
54.8
|
ROE (net income / shareholders' equity)
|
53.2%
|
37.2%
|
12%
|
15.3%
|
13.2%
|
5.29%
|
ROA (Net income/ Total Assets)
|
29.5%
|
22.2%
|
6.93%
|
8.65%
|
6.84%
|
1.88%
|
Assets
1 |
716.2
|
986.2
|
2,272
|
3,692
|
4,410
|
6,550
|
Book Value Per Share
2 |
2.330
|
2.810
|
6.230
|
6.970
|
7.430
|
7.120
|
Cash Flow per Share
2 |
1.050
|
1.230
|
1.250
|
0.7500
|
1.440
|
1.020
|
Capex
1 |
24.2
|
44.7
|
63.3
|
87.6
|
230
|
50.7
|
Capex / Sales
|
3.73%
|
7.43%
|
12.91%
|
9.95%
|
20.32%
|
7.51%
|
Announcement Date
|
10/08/20
|
10/08/20
|
25/04/21
|
30/03/22
|
24/04/23
|
26/04/24
|
|
1st Jan change
|
Capi.
|
---|
| -36.36% | 476M | | +19.99% | 67.97B | | -6.61% | 45.92B | | +22.93% | 43.74B | | +32.85% | 28.16B | | +8.44% | 19.17B | | +15.47% | 17.12B | | -13.18% | 14.73B | | -27.99% | 14.52B | | -32.33% | 11.64B |
Other Specialty Chemicals
|